Zimmer Biomet Holdings, Inc. Stock London S.E.
Equities
0QQD
US98956P1021
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
136.1 CHF | +6.20% | -.--% | -.--% |
Jul. 11 | Citigroup Adjusts Price Target on Zimmer Biomet to $120 From $134 | MT |
Jul. 11 | Citigroup Adjusts Price Target on Zimmer Biomet to $134 From $120 | MT |
Sales 2024 * | 7.76B 6.93B | Sales 2025 * | 8.12B 7.26B | Capitalization | 22.36B 19.99B |
---|---|---|---|---|---|
Net income 2024 * | 998M 892M | Net income 2025 * | 1.2B 1.07B | EV / Sales 2024 * | 3.44 x |
Net Debt 2024 * | 4.35B 3.89B | Net Debt 2025 * | 3.01B 2.69B | EV / Sales 2025 * | 3.13 x |
P/E ratio 2024 * |
22.3
x | P/E ratio 2025 * |
19.2
x | Employees | - |
Yield 2024 * |
0.89% | Yield 2025 * |
0.9% | Free-Float | 64.77% |
Latest transcript on Zimmer Biomet Holdings, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Ivan Tornos
CEO | Chief Executive Officer | 49 | 18-10-31 |
Suketu Upadhyay
DFI | Director of Finance/CFO | 55 | 19-06-30 |
Nitin Goyal
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Higgins
BRD | Director/Board Member | 68 | 06-12-31 |
Betsy Bernard
BRD | Director/Board Member | 68 | 08-12-31 |
Mick Farrell
BRD | Director/Board Member | 51 | 14-12-11 |
Date | Price | Change |
---|---|---|
24-07-11 | - | +-NaN% |
24-07-10 | - | +-NaN% |
24-07-09 | - | +-NaN% |
24-07-08 | - | +-NaN% |
24-07-05 | - | +-NaN% |
Delayed Quote London S.E., January 29, 2021 at 09:41 am EST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.31% | 181B | |
-5.38% | 99.95B | |
-6.04% | 66.21B | |
+16.45% | 45.4B | |
-8.08% | 45.36B | |
+8.38% | 43.84B | |
+12.06% | 29.03B | |
+17.98% | 25.64B | |
-8.28% | 23.53B |
- Stock Market
- Equities
- ZBH Stock
- 0QQD Stock